1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Visualization of a T1-SP on MR imaging in sinonasal melanomas and nonmelanomatous malignant sinonasal tumors based on consensus readinga
Total Hyperintense Foci on T1WI Present Absent T1-SP (+) T1-SP (−) Sinonasal melanomab 31 23 4 4 Nonmelanomatous malignant tumorb 106 3 19 84 Squamous cell carcinoma 45 2 6 37 Lymphoma 22 1 2 19 Adenoid cystic carcinoma 10 0 4 6 Rhabdomyosarcoma 5 0 0 5 Neuroendocrine carcinoma 4 0 2 2 Adenocarcinoma 4 0 2 2 Malignant fibrous histiocytoma 3 0 1 2 Poorly differentiated carcinoma 3 0 0 3 Spindle cell sarcoma 3 0 0 3 Esthesioneuroblastoma 1 0 0 1 Small round cell sarcoma 1 0 1 0 Inflammatory myofibroblastic sarcoma 1 0 0 1 Malignant peripheral nerve sheath tumor 1 0 0 1 Ewing sarcoma 1 0 1 0 Chondrosarcoma 1 0 0 1 Myoepithelial carcinoma 1 0 0 1